The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte p-glycoprotein (pgp) expression in asthmatic children

Journal of Asthma

Volumn 46, Issue 4, 2009, Pages 366-370

  Kopriva, Frantisek ^a   Dzubak, Petr ^a   Potesil, Jan ^a   Hajduch, Marian ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Bronchial asthma; Children; Inhaled corticosteroids; Montelukast; P glycoprotein

Indexed keywords

BUDESONIDE; GLYCOPROTEIN P; MONTELUKAST; MULTIDRUG RESISTANCE PROTEIN 1; ACETIC ACID DERIVATIVE; AUTACOID; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; ANALYTIC METHOD; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; GENETICS; HOSPITALIZATION; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; NEBULIZER; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TREATMENT OUTCOME;

ACETATES; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ASTHMA; BUDESONIDE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; LEUKOTRIENE ANTAGONISTS; MALE; NEBULIZERS AND VAPORIZERS; P-GLYCOPROTEIN; PROBABILITY; QUINOLINES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 67649814198     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900902777767     Document Type: Article

References (25)

1. Bjerner L. Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation. J Allergy Clin Immunol 2007; 120:1269-1275.
2. Kruh GD, Guo Y, Hopper-Borge E, Belinsky MG, Chen Z-S. ABCC10, ABCC11, and ABCC12. Eur J Physiol 2007; 435:675-684.
3. Ambudkar SV, Kim IW, Sauna ZE. The power of the pump: mechanism of action of P-glycoprotein (ABCB1). Eur L Phamrm Sci 2006; 27:392-400.
4. Van der Deen M, de Vries EGE, Timens W, Scheper RJ, Timmer-Bosscha H, Postma DS. ATP-binding cassette (ABC) transporters in normal nad pathological lung. Respir Res 2005; 56:1-16.
5. Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD. Transport of bile acids, sulfated steroide, estradiol 17-beta-D-glucuronide, and leukotrine C4 by human multidrug resistence protein(ABCC11). Mol Pharmacol 2005; 67:545-557.
6. Ren X-Q, Furukawa T, Haraguchi M, Sumizawa T, Aoki S, Kopbayashi M, Akiyama S-i. Function of the ABC signature sequences in the human multidrug resistence protein 1. Mol Pharmacol 2004; 65:1536-1542.
7. Campbell L, Abulrob AN, Kandalaft LE, Plummer S, Hollins AJ, Gibbs A, Gumbleton M: Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures. J Pharmacol Exp Ther 2003; 304:441-452.
8. Litman T, Druley TE, Stein WD, Bates SE. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 2001; 58:931-959.
9. Sarau MH, Ames RS, Chmabers J, Ellis C, Elshourbagy N, Foley JJ, Schmidt DB, Muccitelli RM, Jenkins O, Murdock PR, Herrity NC, Halsey W, Sathe G, Muir AI, Nuthulaganti P, Dytko GM, Buckley PT, Wilson S, Bergggsma DJ, Hay DWP. Identification, molecular cloning, expression, and characterizationofcysteinyl leukotriene receptor. Mol Pharmacol 1999; 56:657-663.
10. Stelmach I, Majak P, Jerzynska J, Kuna P. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma. Clin Exp Allergy 2005; 35:213-220.
11. 4 efflux in lung cancer cells expressing multidrug resistance protein. Biochem Biophys Res Commun 1998; 251:307-312.
12. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/WHO. NIH Publication No. 02-3659, 2002.
13. Hare JT, Elliott DP. Grapefruit juice and potential drug interactions. Konsult Pharm 2003; 18:466-472.
14. Den Boer ML, Zwaan CM, Pieters R, Kazemier KM, Rottier MM, Flens MJ, Scheper RJ, Veerman AJ. Optimal immunocytochemical and flow cytometric detectionof P-gp, MRP and LRPinchildhood acute lymphoblastic leukemia. Leukemia 1997; 11:1078-1085.
15. Sobende PO, Kercsmar CM. Inhaled corticosteroids in asthma management. Respir Care 2008; 53:625-633.
16. Schwiebert EM. ABC transporte-faciliated ATP conductive transport. Am J Physiol 1999; 276:C1-C8.
17. Adcock IM, Ford PA, Bhasvar P, Ahmad T, Chung KF. Steroid resistance in asthma: mechanisms and treatment options. Curr Allergy Asthma Rep 2008; 8:171-178.
18. Funaki S, Takahashi S, Wada N, Murakami H, Farada K. Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome. Pediatr Int. 2008; 50:159-161.
19. Ho EA, Piquette-Miller M. Regulation of multidrug resistance by pro-inflammatory cytokines. Curr Cancer Drug Targets 2006; 6:295-311.
20. Kuzuya Y, Adachi T, Hara H, Anan A, Izuhara K, Nagai H. Induction of drug-metabolizing enzymes and transporters in human bronchial epithelial cells by beclomethasone dipropionate. IUBMB Life 2004; 56:355-359.
21. Henriksson G, Norlander T, Zheng X, Sterna P, Sestrin KM. Expression of P-glycoprotein 170 in nasal mucosa may be increased with topical steroids. Am J Rhinol 1997; 11:317-321.
22. Montano E, Schmitz M, Laser K, Simon H-U. P-Glycoprotein expression in circulating blood leukocytes of patiens with steroid resistant asthma. J Incest Allergol Clin Immunol 1996; 6:14-21.
23. Steinke JW, Culp JA. Leukotriene synthesis inhibitors versus antagonists: The pros and cons. Curr Allergy Asthma Rep 2007; 7:126-133.
24. Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin Immunol 2002; 109:257-263.
25. Evans JF, Ferguson AD, Mosley RT, Hutchinson JH. What's all the FLAP about:5-lipoxygenase-activating protein inhibitors for inflammatory diseases. Trends Pharmacol Sci 2007; 29:72-78.